Chronic pain scores after high-flow nasal oxygen in patients on haemodialysis: A case series
Published
August 19, 2026
Paper ID
PAP-000060
Status
Published
DOI
10.65712/tmj.test000318
Advance Services
Abstract
Background: Practice around high-flow nasal oxygen varies widely between centres. Methods: Eligible participants were patients on haemodialysis. Results: The adjusted odds ratio was 0.72 (95% CI 0.22 to 0.67). The adjusted odds ratio was 0.43 (95% CI 0.20 to 0.67). Conclusion: Future work should test high-flow nasal oxygen in a pragmatic multicentre trial.
Introduction
chronic pain scores remains a leading cause of avoidable harm among patients on haemodialysis. Earlier studies of high-flow nasal oxygen were small or single-centre. The cost of chronic pain scores to health systems is substantial.
Guidelines make only a weak recommendation on high-flow nasal oxygen. Earlier studies of high-flow nasal oxygen were small or single-centre.
Guidelines make only a weak recommendation on high-flow nasal oxygen. Practice around high-flow nasal oxygen varies widely between centres.
Materials and Methods
Missing data were handled with multiple imputation. Analyses were adjusted for age, sex and baseline severity.
Eligible participants were patients on haemodialysis. Analyses were adjusted for age, sex and baseline severity. The primary outcome was chronic pain scores, assessed blind to allocation.
We conducted a case series across 6 centres between 2015 and 2025. Missing data were handled with multiple imputation. We conducted a case series across 11 centres between 2014 and 2024.
Analyses were adjusted for age, sex and baseline severity.
Results
Effects were consistent across prespecified subgroups. 4304 participants were included (median age 60 years). 2640 participants were included (median age 77 years).
2418 participants were included (median age 36 years). The adjusted odds ratio was 0.50 (95% CI 0.32 to 0.60). chronic pain scores occurred in 9% of the intervention group versus 14% of controls.
Serious adverse events were rare and similar between groups. chronic pain scores occurred in 12% of the intervention group versus 30% of controls. The adjusted odds ratio was 0.80 (95% CI 0.42 to 0.80). The adjusted odds ratio was 0.80 (95% CI 0.20 to 0.98).
| Group | n | Events | Rate % | OR |
|---|---|---|---|---|
| Age ≥ 65 | 501 | 95 | 4.9 | 0.71 |
| Intervention | 254 | 58 | 35.2 | 0.89 |
| Centre A | 399 | 77 | 9.8 | 0.66 |
| Centre A | 103 | 83 | 31.2 | 0.62 |
Values are n (%) unless stated otherwise.

Shown for patients on haemodialysis; error bars are 95% confidence intervals.
Serious adverse events were rare and similar between groups. 4637 participants were included (median age 76 years). The adjusted odds ratio was 0.75 (95% CI 0.29 to 0.90). The adjusted odds ratio was 0.50 (95% CI 0.43 to 0.83).
Serious adverse events were rare and similar between groups. chronic pain scores occurred in 21% of the intervention group versus 28% of controls. 1667 participants were included (median age 57 years).
Discussion
Implementation will depend on staffing, cost and local protocols. Strengths include the sample size and blinded outcome assessment. Residual confounding cannot be excluded.
Future work should test high-flow nasal oxygen in a pragmatic multicentre trial. Implementation will depend on staffing, cost and local protocols. Strengths include the sample size and blinded outcome assessment.
Residual confounding cannot be excluded. Implementation will depend on staffing, cost and local protocols.
These findings suggest that high-flow nasal oxygen is associated with better chronic pain scores in patients on haemodialysis. Strengths include the sample size and blinded outcome assessment.
Strengths include the sample size and blinded outcome assessment. Future work should test high-flow nasal oxygen in a pragmatic multicentre trial.
Conclusions
High-flow nasal oxygen should be considered for patients on haemodialysis to improve chronic pain scores.
References
1. Schmidt V, Dubois H, et al. Early mobilisation and chronic pain scores. Pediatrics. 2013;263(5):747-1155.
2. Haddad K, Rossi X, et al. Vitamin D supplementation and patient satisfaction. Ann Intern Med. 2020;63(7):798-1579.
3. Mueller V, Kowalski T, et al. Low-dose aspirin and surgical site infection. BMJ. 2015;311(2):225-947.
4. Patel U, Costa W, et al. Delayed cord clamping and patient satisfaction. Lancet. 2023;220(11):165-1035.
5. Haddad O, Volkov Y, et al. Prone positioning and patient satisfaction. Ann Intern Med. 2016;160(3):545-1039.
6. Dubois K, Farouk Q, et al. Pharmacist-led medication review and acute kidney injury. Lancet. 2023;74(1):405-1075.
7. Mueller P, Kim M, et al. A sepsis alert system and post-operative delirium. Ann Intern Med. 2025;216(4):503-1419.
Appendices
Ethics approval: IRB-4930.